What is Gilead Sciences's accrued rebates?

Gilead Sciences (GILD) reported accrued rebates of $4.12B in Q1 2026.

How has Gilead Sciences's accrued rebates changed year-over-year?

Gilead Sciences's accrued rebates decreased by 1.6% year-over-year, from $4.19B to $4.12B.

What is the long-term trend for Gilead Sciences's accrued rebates?

Over 4 years (2021 to 2025), Gilead Sciences's accrued rebates has grown at a 7.5% compound annual growth rate (CAGR), from $3.24B to $4.34B.

Current Liabilities

Accrued rebates

Gilead Sciences Accrued rebates decreased by 5.0% to $4.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.6%, from $4.19B to $4.12B. Over 4 years (FY 2021 to FY 2025), Accrued rebates shows an upward trend with a 7.5% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Liabilities

First reportedQ4 2021

Last reportedQ1 2026May 7, 2026

Metric ID: current_liabilities_accrued_rebates

Historical Data

15 periods

	Q4 '21	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$3.24B	$3.48B	$3.48B	$3.49B	$3.71B	$3.80B	$4.26B	$3.92B	$4.11B	$3.89B	$4.19B	$4.22B	$4.93B	$4.34B	$4.12B
QoQ Change	—	+7.2%	-0.1%	+0.5%	+6.3%	+2.4%	+12.1%	-8.0%	+4.8%	-5.4%	+7.5%	+0.7%	+17.0%	-12.0%	-5.0%
YoY Change	—	+7.2%	—	—	—	+9.3%	+22.6%	+12.3%	+10.7%	+2.4%	-1.8%	+7.4%	+19.9%	+11.4%	-1.6%

Range$3.24B – $4.93B

CAGR+7.1%

Avg YoY Growth+9.1%

Median YoY Growth+9.3%

Current Streak2 quarters decline

Frequently Asked Questions

What is Gilead Sciences's accrued rebates?: Gilead Sciences (GILD) reported accrued rebates of $4.12B in Q1 2026.
How has Gilead Sciences's accrued rebates changed year-over-year?: Gilead Sciences's accrued rebates decreased by 1.6% year-over-year, from $4.19B to $4.12B.
What is the long-term trend for Gilead Sciences's accrued rebates?: Over 4 years (2021 to 2025), Gilead Sciences's accrued rebates has grown at a 7.5% compound annual growth rate (CAGR), from $3.24B to $4.34B.